Women's Health

Supportive therapies are necessary to help ensure patients adhere to aromatase inhibitor treatment, according to study results presented at San Antonio Breast Cancer Symposium.

Nivolumab plus ipilimumab induced durable responses among a small cohort of women with high tumor mutational burden metastatic HER2-negative breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

Aromatase inhibitors may reduce breast cancer recurrence compared with tamoxifen for certain postmenopausal women with breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

Race did not significantly predict response to treatment outcomes among women with high-risk breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

A cohort of postmenopausal women from Finland had a bone mineral density decrease of about 10% during a follow-up period of 25 years, according to findings published in the Journal of Bone and Mineral Research.

Metformin did not improve outcomes for most patients with early breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

The addition of entinostat to exemestane improved PFS for patients with hormone receptor-positive, HER2-negative advanced breast cancer, according to randomized phase 3 study results presented at San Antonio Breast Cancer Symposium.

Patients with breast cancer who developed tamoxifen-associated uterine cancer had fewer phosphatidylinositol 3-kinase pathway mutations than those with de novo cases, according to results presented at San Antonio Breast Cancer Symposium.

The addition of palbociclib to adjuvant endocrine therapy did not extend invasive DFS for patients with early hormone receptor-positive, HER2-negative breast cancer, according to results presented at San Antonio Breast Cancer Symposium.

An exercise protocol that combined high-intensity interval training and intensive lower-extremity resistance training enhanced training response in women undergoing cardiac rehabilitation compared with standard exercise training.